Skip to main
MDT
MDT logo

Medtronic (MDT) Stock Forecast & Price Target

Medtronic (MDT) Analyst Ratings

Based on 14 analyst ratings
Buy
Strong Buy 14%
Buy 57%
Hold 29%
Sell 0%
Strong Sell 0%

Bulls say

Medtronic is anticipated to raise its FY26 revenue and EPS guidance due to positive performance in the first fiscal quarter and favorable external factors such as currency fluctuations and tariff reductions. The company is expected to experience stronger growth in its Cardiac Ablation segment as the Affera product is set to enter full launch, indicating a competitive edge over its peers. Additionally, ongoing technological advancements are projected to enhance procedural outcomes, further bolstering Medtronic's financial position and outlook.

Bears say

The outlook for Medtronic's stock appears negative due to anticipated revenue growth slowing to low-single digits, driven by challenges such as unsuccessful new product launches and market share decline in certain categories. Additionally, the bear case suggests a flat or declining operating margin, which could lead to earnings that fall below consensus expectations, exacerbated by competitive pressures and adverse currency impacts. Lastly, potential risks such as the commercialization hurdles of key products and the near-term dilution from acquisitions present further headwinds to the company's financial performance.

Medtronic (MDT) has been analyzed by 14 analysts, with a consensus rating of Buy. 14% of analysts recommend a Strong Buy, 57% recommend Buy, 29% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Medtronic and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Medtronic (MDT) Forecast

Analysts have given Medtronic (MDT) a Buy based on their latest research and market trends.

According to 14 analysts, Medtronic (MDT) has a Buy consensus rating as of Oct 22, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $104.07, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $104.07, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Medtronic (MDT)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.